CHR. HANSEN A/S: Financial statements 2013
CVR: 12516479
Source: annual report 2013, Danish Business Authority
01/09/2012 – 31/08/2013
CHR. HANSEN A/S (CVR 12516479) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 3,698,835,000 and a net result of DKK 892,903,000. The profit margin was 24.1%. Equity in the 2013 report amounted to DKK 1,142,337,000. The solvency ratio was 38,075.3%.
- Revenue
- DKK 3,698,835,000
- Gross Profit
- DKK 1,986,227,000
- Profit/Loss
- DKK 892,903,000
- Equity
- DKK 1,142,337,000
- Total Assets
- DKK 3,000,207
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of December 16, 2013, Peer Kurt Rafn has joined the board of directors of CHR. HANSEN A/S.
As of December 16, 2013, Per Poulsen has left the board of directors of CHR. HANSEN A/S.
As of December 16, 2013, Peer Kurt Rafn has left the board of directors of CHR. HANSEN A/S.
As of September 30, 2013, Henrik Dalbøge has stepped down as director of CHR. HANSEN A/S.
As of August 31, 2013, Carsten Hellmann has stepped down as director of CHR. HANSEN A/S.
As of April 1, 2013, Cornelis de Jong has joined the board of directors of CHR. HANSEN A/S.
As of March 31, 2013, Lars Vinge Frederiksen has left the board of directors of CHR. HANSEN A/S.
About CHR. HANSEN A/S
CHR. HANSEN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1988. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named CHR. HANSEN'S LABORATORIUM DANMARK A/S and A/S PSE NR. 2770. The management consists of Morten Enggaard Rasmussen. The board consists of Rainer Chapour Lehmann (chair), Anders Lund, Helle Rexen and Lisbet Kragelund. The company is owned by NOVOZYMES A/S. The company has 1,747 employees (2026). In 2025, the company reported revenue of DKK 6,820,616,000 and a net result of DKK 2,105,477,000 compared with DKK 1,891,419,000 the year before. Equity in the 2025 report amounted to DKK 11,263,718,000.